By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kowa Pharmaceuticals America 

5331 Perimeter Parkway Court

Montgomery  Alabama  36116  U.S.A.
Phone: 334-288-1288 Fax: 334-288-2788



Company News
Kowa Pharmaceuticals America Announces INTREPID Trial Results In The Lancet HIV Showing Superior LDL Cholesterol Reduction With LIVALO (Pitavastatin) Compared With Pravastatin In Adults With HIV And Dyslipidemia 4/19/2017 8:34:41 AM
Kowa Pharmaceuticals America Announces Agreement With CymaBay Therapeutics To License Gout Compound 1/4/2017 10:05:11 AM
Kowa Pharmaceuticals America Release: New Data Demonstrate Pitavastatin More Effective Than Pravastatin In Improving Inflammatory And Immune Activation Markers In HIV-Infected Patients 6/21/2016 6:39:56 AM
Kowa Pharmaceuticals America Release: New Meta-Analysis On Pitavastatin Demonstrates No Adverse Effect Compared With Placebo Or Other Statins On New-Onset Diabetes In Non-Diabetic Patients At Risk For Cardiovascular Disease 5/4/2015 6:28:35 AM
Kowa Pharmaceuticals America Release: Landmark Trial To Explore The Prevention Of Heart Disease In People Living With HIV 10/28/2014 8:29:16 AM
Kowa Pharmaceuticals America Release: Data Showed After 52 Weeks, LIVALO® (Pitavastatin) 4 Mg Maintained Similar Safety And Significantly Greater LDL-C Reduction Compared With Pravastatin 40 Mg In HIV-Infected Adults With Dyslipidemia 5/1/2014 8:57:52 AM
Amarin Corporation PLC (AMRN) And Kowa Pharmaceuticals America Announce U.S. Co-Promotion Agreement For Vascepa® (Icosapent Ethyl) Capsules 4/1/2014 11:05:15 AM
Kowa Pharmaceuticals America Release: New Data Showed LIVALO® (pitavastatin) 4 mg had Neutral Effects on Fasting Serum Glucose and HbA1c Levels in HIV-infected Adults with Dyslipidemia 6/17/2013 11:46:12 AM
Kowa Pharmaceuticals America Release: New Superiority Trial Showed LIVALO® (Pitavastatin) 4 mg Provided Significantly Greater LDL-C Reduction in HIV-Infected Adults With Dyslipidemia Versus Pravastatin 40 mg 3/7/2013 10:21:35 AM
Kowa Pharmaceuticals America, Eli Lilly and Company (LLY) Release Results From a Pharmacokinetic Study 7/23/2012 7:54:22 AM